Join BIA, Stifel and colleagues from the investment sector at this informal networking breakfast on 29 September.
Open to investors, fund managers and brokers ONLY
BIA and our hosts Stifel invite you to join them for a special panel event to discuss the Patient Capital Review and other factors that will impact the growth of the UK biotech sector in the coming years. We’ll be joined by ex-science and Treasury minister, Lord David Willetts, to give his personal insight and experience, alongside other experts on the sector.
Special guest, Lord David Willetts
08.00 Registration and networking breakfast
09.00 Review of BIA/Informa Q2 Finance Report. Max Herrmann, Managing Director, Stifel
09.10 Brexit and the future of regulation. Steve Bates OBE, Chief Executive Officer, BIA
09.25 The future of the UK - Industrial Strategy and Patient Capital Review.
Panel: Steve Bates to be joined by Max Herrmann and Lord David Willetts
10.00 Refreshments and networking
Free of charge, but open to investors, fund managers and brokers ONLY
BIA 2017 Supporters